Q2 2022 Holdings
Filed 2022-08-16 | 78 holdings | $9.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Concert Pharmaceuticals I(CNCEEUR) | COM | 206022105 | $620.0K | 2,610 | 6.5% |
| Aurinia Pharmaceuticals I(AUPH) | COM | 05156V102 | $573.5K | 5,758 | 6.0% |
| Dyne Therapeutics Inc COM(DYN) | COM | 26818M108 | $562.6K | 3,865 | 5.9% |
| I-Mab Sponsored ADS(NBP) | SPONSORED ADS | 44975P103 | $553.0K | 6,232 | 5.8% |
| Uniqure N.V. COM Eur0.05(QURE) | SHS | N90064101 | $446.5K | 8,318 | 4.7% |
| Kalvista Pharmaceuticals(KALV) | COM | 483497103 | $383.2K | 3,760 | 4.0% |
| Travere Therapeutics Inc(TVTX) | COM | 89422G107 | $380.0K | 9,215 | 4.0% |
| Exelixis Inc COM(EXEL) | COM | 30161Q104 | $350.0K | 7,290 | 3.7% |
| Chinook Therapeutics Inc(290A) | COM | 16961L106 | $340.4K | 5,947 | 3.6% |
| Supernus Pharmaceuticals(SUPN) | COM | 868459108 | $297.5K | 8,604 | 3.1% |
| Horizon Therapeutics PLC | SHS | G4617B105 | $287.0K | 22,915 | 3.0% |
| Vera Therapeutics(VERA) | CL A | 92337R101 | $281.1K | 3,825 | 2.9% |
| Iovance Biotherapeutics I(IOVA) | COM | 462260100 | $273.0K | 3,011 | 2.8% |
| Caribou Biosciences Inc C(CRBU) | COM | 142038108 | $254.7K | 1,378 | 2.7% |
| Incyte Corp Inc COM(INCY) | COM | 45337C102 | $238.0K | 18,081 | 2.5% |
| Neurocrine Biosciences in(NBIX) | COM | 64125C109 | $236.0K | 23,008 | 2.5% |
| Harmony Biosciences Holdi(HRMY) | COM | 413197104 | $221.5K | 10,794 | 2.3% |
| Fulcrum Therapeutics Inc(FULC) | COM | 359616109 | $193.7K | 949 | 2.0% |
| Ultragenyx Pharmaceutical(RARE) | COM | 90400D108 | $161.1K | 9,610 | 1.7% |
| Fate Therapeutics Inc COM(FATE) | COM | 31189P102 | $158.0K | 3,917 | 1.6% |
| Gilead Sciences Inc Commo(GILD) | COM | 375558103 | $145.8K | 9,012 | 1.5% |
| Mirati Therapeutics Inc C(MRTXEUR) | COM | 60468T105 | $136.0K | 9,131 | 1.4% |
| Novavax Inc(NVAX) | COM | 670002401 | $132.5K | 6,814 | 1.4% |
| Galapagos(GLPG) | SPONSORED ADR | 36315X101 | $123.3K | 6,876 | 1.3% |
| Chemocentryx Inc COM STK(CCXIEUR) | COM | 16383L106 | $121.1K | 3,000 | 1.3% |
| Ideaya Biosciences Inc Co(IDYA) | COM | 45166A102 | $109.0K | 1,501 | 1.1% |
| Gamida Cell | SHS | M47364100 | $107.0K | 187 | 1.1% |
| Amicus Therapeutics Inc C(FOLD) | COM | 03152W109 | $94.6K | 1,017 | 1.0% |
| Biomarin Pharmaceutical I(BMRN) | COM | 09061G101 | $79.7K | 6,601 | 0.8% |
| ZAI LAB LTD ADR(ZLAB) | ADR | 98887Q104 | $79.0K | 2,736 | 0.8% |
| Guardant Health Inc COM(GH) | COM | 40131M109 | $74.5K | 3,005 | 0.8% |
| Hutchmed China Limited SP(HCM) | SPONSORED ADS | 44842L103 | $68.0K | 859 | 0.7% |
| Seagen Inc COM(SGENUSD) | COM | 81181C104 | $65.6K | 11,607 | 0.7% |
| Intra-Cellular Therapies(ITCIEUR) | COM | 46116X101 | $63.2K | 3,603 | 0.7% |
| Rocket Pharmaceuticals in(RCKT) | COM | 77313F106 | $63.0K | 868 | 0.7% |
| Immunovant Inc COM(IMVT) | COM | 45258J102 | $60.0K | 233 | 0.6% |
| Ironwood Pharmaceuticals(IRWD) | COM | 46333X108 | $60.0K | 692 | 0.6% |
| Genmab(GMAB) | SPONSORED ADS | 372303206 | $57.2K | 1,857 | 0.6% |
| Biocryst Pharmaceuticals(BCRX) | COM | 09058V103 | $57.0K | 602 | 0.6% |
| Biogen Inc Common Stock(BIIB) | COM | 09062X103 | $52.0K | 10,606 | 0.5% |
| Alkermes PLC SHS(ALKS) | SHS | G01767105 | $51.0K | 1,519 | 0.5% |
| Allogene Therapeutics Inc(ALLO) | COM | 019770106 | $50.0K | 570 | 0.5% |
| Avadel Pharmaceuticals PL | Sponsored ADR | 05337M104 | $50.0K | 122 | 0.5% |
| Illumina Inc COM(ILMN) | COM | 452327109 | $48.0K | 8,850 | 0.5% |
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $46.1K | 1,703 | 0.5% |
| Krystal Biotech Inc COM(KRYS) | COM | 501147102 | $45.0K | 2,955 | 0.5% |
| Black Diamond Therapeutic | COM | 0920E3105 | $44.0K | 107 | 0.5% |
| Amgen Inc COM(AMGN) | COM | 031162100 | $40.7K | 9,915 | 0.4% |
| Insmed Inc COM PAR $.01(INSM) | COM | 457669307 | $40.1K | 791 | 0.4% |
| Denali Therapeutics Inc C(DNLI) | COM | 24823R105 | $38.0K | 1,118 | 0.4% |